May 2021
-
05.26.2021 Partnerships The Foundation for the NIH Announces a New Research Initiative to Find Integrated Treatments Across Common Metabolic Diseases -
05.19.2021 Partnerships Sosei Heptares announces that the third novel drug candidate from its multi-target drug discovery collaboration with Pfizer has started clinical trials
April 2021
-
04.29.2021 Partnerships Pfizer Ventures' Barbara Dalton Appointed as AMRA Medical's Newest Board Member -
04.28.2021 Partnerships Pfizer Acquires Amplyx Pharmaceuticals -
04.14.2021 Partnerships AMRA Medical Generates Largest Imaging Dataset on Body Composition Profiling
March 2021
-
03.17.2021 Partnerships Mediar Therapeutics Adds New Investors As It Advances Anti-Fibrotic Treatments
February 2021
-
02.17.2021 Partnerships Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder -
02.09.2021 Corporate Partnerships Pfizer And Ida Foundation Partner To Expand Access To Essential Cancer Treatments In 70 Low-And Lower-Middle-Income Countries New Partnership Broadens Access To Oncology Treatments Across Latin America, Asia, Africa And The Western Pacific. -
02.08.2021 Partnerships Palleon Pharmaceuticals Appoints Nikola Trbovic to its Board of Directors
January 2021
-
01.22.2021 Partnerships Ten Leading BioPharma Companies Announce Formation of Accumulus Synergy to Develop Global Data Sharing Platform -
01.21.2021 Partnerships Cerevel Therapeutics Announces the Appointments of Deval Patrick and Deborah Baron to its Board of Directors -
01.12.2021 Partnerships Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.